{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:18:59Z","timestamp":1794550739390,"version":"4.9.1"},"reference-count":52,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Haploidentical allogeneic hematopoietic stem cell transplantation (h-HSCT) is increasingly used in patients lacking an HLA-matched donor. In this context, the combination of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG) effectively prevents graft-versus-host disease, but its impact on the reconstitution of peripheral blood natural killer (NK) cell subsets remains insufficiently characterized. In this study, NK cell subsets were analyzed in depth in 56 adult recipients of unmanipulated h-HSCT with PTCy and ATG. Peripheral blood samples were collected at days +30, +60, and +100 after transplant. NK cell immunophenotype and cytotoxic function were assessed using multiparameter flow cytometry with unsupervised clustering, and degranulation assays against lymphoid and myeloid targets. Data were compared with those from 200 healthy volunteers. In spite of early numerical reconstitution, NK cells exhibited an immature immunophenotype with a low expression of activation markers. Cytotoxic activity against lymphoid targets was preserved, but degranulation against acute myeloid leukemia cell lines was significantly impaired across all NK subsets, including phenotypically mature NK cells. Cytomegalovirus reactivation was associated with an expansion of memory-like NK subsets but did not enhance degranulation. Functional education via killer cell immunoglobulin\u2013like receptors was lost by day +30 and progressively reacquired from day +60 onward, in a pattern primarily influenced by the HLA-C genotype of recipients. These results indicate that, after h-HSCT with PTCy and ATG, NK cell subsets recover in number but fail to achieve early functional competence, particularly against myeloid targets. Strategies aiming at restoring mature NK cell functions warrant prospective investigations, especially in high-risk myeloid malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017707","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:22:29Z","timestamp":1761913349000},"page":"665-681","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-6570","authenticated-orcid":false,"given":"Maxime","family":"Jullien","sequence":"first","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4029-9210","authenticated-orcid":false,"given":"Enora","family":"Ferron","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Willem","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"David","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Legrand","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Duquesne","sequence":"additional","affiliation":[{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bouzy","sequence":"additional","affiliation":[{"name":"4Hematology Biology, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0975-0440","authenticated-orcid":false,"given":"Mathilde","family":"Bastien","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Garnier","sequence":"additional","affiliation":[{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Le Bourgeois","sequence":"additional","affiliation":[{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Gagne","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"2Hematology Department, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5943-6990","authenticated-orcid":false,"given":"Christelle","family":"Reti\u00e8re","sequence":"additional","affiliation":[{"name":"1INSERM, CNRS, CRCI2NA, U1307, UMR6075, Nantes Universit\u00e9, Nantes, France"},{"name":"3Laboratoire de Recherche, Etablissement Fran\u00e7ais du Sang Centre - Pays de la Loire, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"6","key":"2026021015532302900_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41409-024-02248-9","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT","volume":"59","author":"Passweg","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"2026021015532302900_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/978-3-030-02278-5_65","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Ciceri","year":"2019","edition":"7th ed"},{"issue":"17","key":"2026021015532302900_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"2026021015532302900_bib4","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.exphem.2006.08.009","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3\/CD19 depletion: fast engraftment and low toxicity","volume":"34","author":"Bethge","year":"2006","journal-title":"Exp Hematol"},{"issue":"5","key":"2026021015532302900_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2026021015532302900_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2026021015532302900_bib7","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2026021015532302900_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clml.2020.04.003","article-title":"Impact of adding antithymocyte globulin to posttransplantation cyclophosphamide in haploidentical stem-cell transplantation","volume":"20","author":"El-Cheikh","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026021015532302900_bib9","doi-asserted-by":"crossref","first-page":"09636897221139103","DOI":"10.1177\/09636897221139103","article-title":"Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as an effective regimen for prophylaxis of graft versus host disease after haploidentical peripheral blood stem cell transplantation with maternal\/collateral related donors","volume":"31","author":"Li","year":"2022","journal-title":"Cell Transplant"},{"issue":"6","key":"2026021015532302900_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41409-023-01956-y","article-title":"Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival","volume":"58","author":"Jullien","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2026021015532302900_bib11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41409-023-02085-2","article-title":"Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2026021015532302900_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/leu.2010.235","article-title":"Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3\/CD19 depleted grafts","volume":"25","author":"Federmann","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"2026021015532302900_bib13","doi-asserted-by":"crossref","first-page":"e13147","DOI":"10.1111\/ctr.13147","article-title":"Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using \u03b1\u03b2 T cell-depleted grafts and the clinical implication of \u03b3\u03b4 T cells","volume":"32","author":"Park","year":"2018","journal-title":"Clin Transplant"},{"issue":"1","key":"2026021015532302900_bib14","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S2352-3026(19)30157-7","article-title":"Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14\/L): a randomised, non-inferiority, phase 3 trial","volume":"7","author":"Beelen","year":"2020","journal-title":"Lancet Haematol"},{"issue":"14","key":"2026021015532302900_bib15","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.18632\/oncotarget.24328","article-title":"Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation","volume":"9","author":"Reti\u00e8re","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"2026021015532302900_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4049\/jimmunol.2000578","article-title":"Posttransplant cyclophosphamide and antithymocyte globulin versus posttransplant cyclophosphamide as graft-versus-host disease prophylaxis for peripheral blood stem cell haploidentical transplants: comparison of T cell and NK effector reconstitution","volume":"205","author":"Makanga","year":"2020","journal-title":"J Immunol"},{"issue":"1","key":"2026021015532302900_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling NK cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"19","key":"2026021015532302900_bib18","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood"},{"key":"2026021015532302900_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.immunol.19.1.291","article-title":"Regulation of the natural killer cell receptor repertoire","volume":"19","author":"Raulet","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"2026021015532302900_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"issue":"5562","key":"2026021015532302900_bib21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"4","key":"2026021015532302900_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000323935","article-title":"Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?","volume":"3","author":"Nguyen","year":"2011","journal-title":"J Innate Immun"},{"issue":"2","key":"2026021015532302900_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/eji.201747134","article-title":"NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD","volume":"48","author":"Chan","year":"2018","journal-title":"Eur J Immunol"},{"issue":"8","key":"2026021015532302900_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.10.058","article-title":"Intra-lineage plasticity and functional reprogramming maintain natural killer cell repertoire diversity","volume":"29","author":"Pfefferle","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"2026021015532302900_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"key":"2026021015532302900_bib26","doi-asserted-by":"crossref","first-page":"1389358","DOI":"10.3389\/fimmu.2024.1389358","article-title":"Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence","volume":"15","author":"Ferron","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"2026021015532302900_bib27","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.1801489","article-title":"Impact of KIR\/HLA incompatibilities on NK cell reconstitution and clinical outcome after T cell-replete haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide","volume":"202","author":"Willem","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"2026021015532302900_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1399-0039.2004.00303.x","article-title":"Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping","volume":"64","author":"Sun","year":"2004","journal-title":"Tissue Antigens"},{"issue":"10","key":"2026021015532302900_bib29","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3390\/cancers15102754","article-title":"Non-expressed donor KIR3DL1 alleles may represent a risk factor for relapse after T-replete haploidentical hematopoietic stem cell transplantation","volume":"15","author":"Legrand","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026021015532302900_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fimmu.2017.00547","article-title":"Killer immunoglobulin-like receptor allele determination using next-generation sequencing technology","volume":"8","author":"Maniangou","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"2026021015532302900_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"issue":"201","key":"2026021015532302900_bib32","first-page":"1","article-title":"Understanding how dimension reduction tools work: an empirical approach to deciphering t-SNE, UMAP, TriMap, and PaCMAP for data visualization","volume":"22","author":"Wang","year":"2021","journal-title":"J Machine Learn Res"},{"issue":"9","key":"2026021015532302900_bib33","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.4049\/jimmunol.142.9.3320","article-title":"Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line","volume":"142","author":"Shimizu","year":"1989","journal-title":"J Immunol"},{"issue":"446","key":"2026021015532302900_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"2026021015532302900_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann Appl Stat"},{"issue":"23","key":"2026021015532302900_bib37","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2026021015532302900_bib36","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2026021015532302900_bib38","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2026021015532302900_bib39","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.178.6.3918","article-title":"Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor","volume":"178","author":"Fischer","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"2026021015532302900_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood-2010-03-273656","article-title":"Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition","volume":"117","author":"Sch\u00f6nberg","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2026021015532302900_bib41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2026021015532302900_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/bloodadvances.2021005509","article-title":"Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG","volume":"6","author":"Turki","year":"2022","journal-title":"Blood Adv"},{"issue":"12","key":"2026021015532302900_bib43","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/bloodadvances.2022009376","article-title":"CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia","volume":"7","author":"Akahoshi","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"2026021015532302900_bib44","doi-asserted-by":"crossref","first-page":"465.e1","DOI":"10.1016\/j.jtct.2025.04.021","article-title":"Impact of cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation on the relapse of acute leukemia","volume":"31","author":"Park","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"2026021015532302900_bib45","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2026021015532302900_bib46","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1182\/blood-2024-203972","article-title":"Letermovir provides protection against clinically significant CMV infections in CMV-seronegative recipients of an allotransplant from a CMV-seropositive donor","volume":"144","author":"Letailleur","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026021015532302900_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10875-025-01913-y","article-title":"Molecular interactions between NK cells and acute leukemic cells: KIR2DL5 drastically limits NK cell responses","volume":"45","author":"Ferron","year":"2025","journal-title":"J Clin Immunol"},{"issue":"6","key":"2026021015532302900_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.06.029","article-title":"Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from function","volume":"138","author":"Gao","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2026021015532302900_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"issue":"16","key":"2026021015532302900_bib50","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo\u2013expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2026021015532302900_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41375-021-01349-4","article-title":"Decrease post-transplant relapse using donor-derived expanded NK-cells","volume":"36","author":"Ciurea","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2026021015532302900_bib52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajh.27191","article-title":"Phase I study of zoledronic acid combined with escalated doses of interleukin-2 for early in vivo generation of V\u03b39V\u03b42 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide","volume":"99","author":"Jullien","year":"2024","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/665\/2501512\/blooda_adv-2025-017707-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/665\/2501512\/blooda_adv-2025-017707-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:53:36Z","timestamp":1770756816000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/665\/548000\/Functional-recovery-of-NK-cells-after-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017707","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,1,29]]}}}